NCT05901025View on ClinicalTrials.gov

Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients

Not yet recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2033

Conditions
Breast Cancer
All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT05901025 - Homologous Recombination Repair Pathway Gene Mutation Spectrum in Chinese Breast Cancer Patients | Biotech Hunter | Biotech Hunter